Details

Autor(en) / Beteiligte

• Aakhus, A. M.
• Stavem, P.
• Hovig, T.
• Pedersen, T. M.
• Solum, N. O.

Titel

Studies on a patient with thrombocytopenia, giant platelets and a platelet membrane glycoprotein Ib with reduced amount of sialic acid

Ist Teil von

• British journal of haematology, 1990-03, Vol.74 (3), p.320-329

Ort / Verlag

Oxford, UK: Blackwell Publishing Ltd

Erscheinungsjahr

1990

Quelle

MEDLINE

Beschreibungen/Notizen

• Summary A 70‐year‐old patient with a life‐long bleeding tendency, giant platelets and thrombocytopenia (10‐40 x 109 platelets/1) has been studied. This is a condition often associated with lack of platelet membrane glycoprotein Ib (GP Ib). Electron microscopy of fixed platelets incubated with monoclonal antibodies to GP Ib (AN 51, AP 1) and goldlabelled goat anti‐mouse IgG, showed a distinct distribution of GP Ib on the patient's platelets, however. Crossed immunoelectrophoresis and SDS‐PAGE demonstrated a reduced mobility of the patient's GP Ib which could be explained by absence of sialic acid. Blotting with peroxidase‐conjugated peanut agglutinin confirmed this conclusion. This lectin binds to galactose‐N‐acetyl‐galactosamine residues exposed terminally when sialic acid is absent from the carbohydrate side‐chains. Such binding could be seen with normal GP Ib only after neuraminidase treatment. Fluorescence studies with FITC‐conjugated peanut agglutinin showed binding of the lectin to intact patient platelets, indicating that lack of sialic acid was not introduced during the platelet isolation procedure. Neither could the lack of sialic acid be attributed to increased neuraminidase activity as studied in vitro. Platelets treated with neuraminidase in vivo or in vitro are rapidly cleared from the circulation. Therefore the patient's thrombocytopenia may be associated with the reduced amount of GP Ib sialic acid. As far as we know, similar cases have not been described previously.